Marshall Wace’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Marshall Wace’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-72,475	Closed	-$741K	–	3206
2023 Q1	$741K	Sell	72,475 -223,411	-76%	-$2.27M	﹤0.01%	1944
2022 Q4	$2.97M	Hold	295,886	–	–	0.01%	1513
2022 Q3	$2.92M	Buy	295,886 +20,911	+8%	+$205K	0.01%	1774
2022 Q2	$2.68M	Hold	274,975	–	–	0.01%	1793
2022 Q1	$2.68M	Hold	274,975	–	–	0.01%	1868
2021 Q4	$2.66M	Hold	274,975	–	–	﹤0.01%	1852
2021 Q3	$2.7M	Buy	+274,975	New	+$2.68M	0.01%	1334

Marshall Wace's ORIA Position: Q2 2023 in Review

Marshall Wace sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 72,475 shares — an estimated $741K sold.

Marshall Wace first reported a position in ORIA in Q3 2021 and held it in 7 quarters. The position peaked at $2.97M in Q4 2022. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Marshall Wace reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Marshall Wace sold 72,475 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $741K.
Marshall Wace first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2021 and held it in 7 quarters.
Marshall Wace's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $2.97M in Q4 2022.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.